News
XTLB
2.560
-1.16%
-0.030
Weekly Report: what happened at XTLB last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at XTLB last week (0408-0412)?
Weekly Report · 04/15 09:33
Weekly Report: what happened at XTLB last week (0401-0405)?
Weekly Report · 04/08 09:35
XTL Biopharmaceuticals Regains Nasdaq Compliance
TipRanks · 04/02 20:57
Weekly Report: what happened at XTLB last week (0325-0329)?
Weekly Report · 04/01 09:35
12 Health Care Stocks Moving In Wednesday's Intraday Session
Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. Nutriband stock rose 24.33% as the company's Q4 earnings came out yesterday. Lixte Biotechnology and Ontrak also moved upwards.
Benzinga · 03/27 16:31
OCGN, DNMR and DERM are among pre market gainers
Stoke Therapeutics (STOK) and Check-Cap (CHEK) are among pre market gainers. Krispy Kreme (DNUT) soars 20% ahead of Nasdaq debut today. Reddit (RDDT) jumps 30% as shares jump 30% on Monday.
Seeking Alpha · 03/26 12:33
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Stoke Therapeutics stock is rocketing more than 81% alongside positive Phase 1/2a studies data. The biggest pre-market stock movers on Tuesday are pharmaceutical updates, earnings reports, collaboration agreements and more. Tidal Trust II YieldMax MRNA Option Income Strategy ETF (MRNY) stock is plummeting 60% this morning.
Investorplace · 03/26 11:36
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Landos Biopharma, Inc. Shares jumped 171.2% to $21.70 on Monday. AbbVie and Landos signed a definitive agreement to acquire the company. Altamira Therapeutics Ltd. Shares climbed 70.1% after falling around 22% on Friday. GameStop Corp. Shares rose 8.4% after the company announced a separation.
Benzinga · 03/25 18:44
12 Health Care Stocks Moving In Monday's Intraday Session
Landos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The company's, Q4 earnings report came out 2 days ago. Sagimet Biosciences ( NASDAQ:SGMT) and XTL Biopharmaceuticals also moved upwards. Trxade Health stock decreased by 48.6% during the regular session to $12.38.
Benzinga · 03/25 17:30
CGC, CYTO and IDN are among mid-day movers
On the Move CGC, CYTO and IDN are among mid-day movers. Landos Biopharma and MoneyHero are among the biggest gainers. Australian Oilseeds and Aehr Test Systems are among those that lost ground in the last 24 hours.
Seeking Alpha · 03/25 17:25
Weekly Report: what happened at XTLB last week (0318-0322)?
Weekly Report · 03/25 09:36
STEM, SOUN and GRFS among pre-market losers & stocks
On the Move STEM, SOUN and GRFS among pre-market losers & stocks. Ispire Technology, Lululemon Athletica and Cutera among the losers after Q4 earnings release. NKE, STEM, XTLB, ETPBM, BTOG, and SOUN among the winners.
Seeking Alpha · 03/22 12:23
XTL Biopharmaceuticals Convenes Extraordinary General Meeting
TipRanks · 03/21 20:58
12 Health Care Stocks Moving In Wednesday's After-Market Session
XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The company's Q4 earnings report came out 2 days ago. Jaguar Health and Leap Therapeutics were among the gainers.
Benzinga · 03/20 21:34
Dow Surges 350 Points; Fed Holds Rates Steady
U.S. Stocks traded higher on Wednesday after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08%. The Fed kept interest rates unchanged between 5.25% and 5.5% at its March meeting. Industrials shares rose by 0.4% on Wednesday; health care shares fell 0.7%. European markets closed mixed; Asian markets closed higher.
Benzinga · 03/20 19:22
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. Dipped 31.7% to $4.91 on Wednesday. ETAO International Co., Ltd. Shares shot up 111.5% after the company announced a reverse stock split. NuScale Power Corporation shares tumbled around 35% after spiking 17% on Tuesday.
Benzinga · 03/20 18:03
12 Health Care Stocks Moving In Wednesday's Intraday Session
XTL Biopharmaceuticals shares moved upwards by 95.8% to $2.04 during Wednesday's regular session. Etao International Co (NASDAQ:ETAO) stock rose 84.65% in the session. Annovis Bio (NYSE:ANVS) shares moved up by 39.12%. The company's Q4 earnings report came out yesterday.
Benzinga · 03/20 17:31
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
U.S. Stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% on Wednesday. Crude oil inventories in the US declined by 1.952 million barrels in the week ended March 15. ETAO International Co. Shares rose by 0.5% in trading on Wednesday; Asian markets closed higher. Euro zone European shares closed mixed.
Benzinga · 03/20 16:47
BUZZ-U.S. STOCKS ON THE MOVE-J.Jill, LivaNova, International Paper
Wall Street's main stock indexes were little changed on Wednesday. The Dow Jones Industrial Average was up 0.02% at 39,118.45. Chipotle Mexican Grill and American Airlines Group were among the top gainers. The Federal Reserve is expected to keep interest rates unchanged at its meeting.
Reuters · 03/20 16:20
More
Webull provides a variety of real-time XTLB stock news. You can receive the latest news about Xtl Biopharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About XTLB
XTL Biopharmaceuticals Ltd is an Israel-based biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.